REVVITY, INC Sales Revenue, Goods, Net (Deprecated 2018-01-31)
REVVITY, INC (RVTY) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $447.61 million for the 3-month period ending 2018-04-01, per its 10-Q filed 2018-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-05-08
- REVVITY, INC sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-04-01 was $447.61M, a 34.13% increase year-over-year.
- REVVITY, INC sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $433.88M, a 13.98% increase year-over-year.
- REVVITY, INC sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-10-01 was $354.82M, a 5.95% increase year-over-year.
- REVVITY, INC sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-07-02 was $355.00M, a 0.55% decline year-over-year.
- REVVITY, INC sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $1.48B, a 5.76% increase from fiscal 2017.
- REVVITY, INC sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $1.40B, a 0.13% increase from fiscal 2016.
- REVVITY, INC sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $1.40B, a 1.63% increase from fiscal 2014.
- REVVITY, INC sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $1.37B, a 8.37% decline from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-04-01 | $447.61M 10-Q · filed 2018-05-08 | $881.49M derived: sum of 2 quarters · filed 2018-05-08 | $1.24B derived: sum of 3 quarters · filed 2018-05-08 | $1.59B derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-12-31 | $433.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $788.70M derived: sum of 2 quarters · filed 2018-02-27 | $1.14B derived: sum of 3 quarters · filed 2018-02-27 | $1.48B 10-K · filed 2018-02-27 | ||||
| 2017-10-01 | $354.82M 10-Q · filed 2017-11-07 | $709.82M derived: sum of 2 quarters · filed 2017-11-07 | $1.04B 10-Q · filed 2017-11-07 | $1.42B derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-07-02 | $355.00M 10-Q · filed 2017-08-08 | $688.72M 10-Q · filed 2017-08-08 | $1.07B derived: sum of 3 quarters · filed 2018-05-08 | $1.40B derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-04-02 | $333.71M 10-Q · filed 2018-05-08 | $714.39M derived: sum of 2 quarters · filed 2018-05-08 | $1.05B derived: sum of 3 quarters · filed 2018-05-08 | $1.41B derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2017-01-01 | $380.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $715.57M derived: sum of 2 quarters · filed 2018-02-27 | $1.07B derived: sum of 3 quarters · filed 2018-02-27 | $1.40B 10-K · filed 2018-02-27 | ||||
| 2016-10-02 | $334.89M 10-Q · filed 2017-11-07 | $368.46M 10-Q · filed 2016-11-08 | $691.87M derived: sum of 2 quarters · filed 2017-11-07 | $1.02B 10-Q · filed 2017-11-07 | $1.13B 10-Q · filed 2016-11-08 | $1.28B derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-07-03 | $356.98M 10-Q · filed 2017-08-08 | $393.40M 10-Q · filed 2016-08-09 | $681.33M 10-Q · filed 2017-08-08 | $758.42M 10-Q · filed 2016-08-09 | $950.07M derived: sum of 3 quarters · filed 2018-02-27 | $1.33B derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-04-03 | $324.35M 10-Q · filed 2017-05-09 | $365.02M 10-Q · filed 2016-05-10 | $593.10M derived: sum of 2 quarters · filed 2018-02-27 | $971.42M derived: sum of 3 quarters · filed 2018-02-27 | $1.36B derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-01-03 | $268.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $647.07M derived: sum of 2 quarters · filed 2018-02-27 | $1.04B derived: sum of 3 quarters · filed 2018-02-27 | $1.40B 10-K · filed 2018-02-27 | $1.55B 10-K · filed 2016-03-01 | |||
| 2015-10-04 | $378.32M 10-Q · filed 2016-11-08 | $767.04M derived: sum of 2 quarters · filed 2016-11-08 | $1.13B 10-Q · filed 2016-11-08 | $1.39B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-28 | $388.72M 10-Q · filed 2016-08-09 | $748.03M 10-Q · filed 2016-08-09 | $1.01B derived: sum of 3 quarters · filed 2017-02-28 | $1.37B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-29 | $359.31M 10-Q · filed 2016-05-10 | $619.02M derived: sum of 2 quarters · filed 2017-02-28 | $984.96M derived: sum of 3 quarters · filed 2017-02-28 | $1.37B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-28 | $259.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $625.64M derived: sum of 2 quarters · filed 2017-02-28 | $1.01B derived: sum of 3 quarters · filed 2017-02-28 | $1.37B 10-K · filed 2017-02-28 | $1.54B 10-K · filed 2015-02-24 | |||
| 2014-09-28 | $365.93M 10-Q · filed 2015-11-10 | $747.54M derived: sum of 2 quarters · filed 2015-11-10 | $1.11B 10-Q · filed 2015-11-10 | $1.53B derived: sum of 4 quarters · filed 2016-03-01 | ||||
| 2014-06-29 | $381.61M 10-Q · filed 2015-08-04 | $747.09M 10-Q · filed 2015-08-04 | $1.17B derived: sum of 3 quarters · filed 2016-03-01 | $1.52B derived: sum of 4 quarters · filed 2016-03-01 | ||||
| 2014-03-30 | $365.49M 10-Q · filed 2015-05-05 | $787.17M derived: sum of 2 quarters · filed 2016-03-01 | $1.14B derived: sum of 3 quarters · filed 2016-03-01 | $1.52B derived: sum of 4 quarters · filed 2016-03-01 | ||||
| 2013-12-29 | $421.68M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $777.43M derived: sum of 2 quarters · filed 2016-03-01 | $1.15B derived: sum of 3 quarters · filed 2016-03-01 | $1.50B 10-K · filed 2016-03-01 | ||||
| 2013-09-29 | $355.75M 10-Q · filed 2014-11-04 | $729.77M derived: sum of 2 quarters · filed 2014-11-04 | $1.08B 10-Q · filed 2014-11-04 | $1.48B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $374.02M 10-Q · filed 2014-08-05 | $374.02M 10-Q · filed 2013-08-06 | $720.64M 10-Q · filed 2014-08-05 | $720.64M 10-Q · filed 2013-08-06 | $1.12B derived: sum of 3 quarters · filed 2015-02-24 | $1.47B derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $346.62M 10-Q · filed 2014-05-06 | $750.79M derived: sum of 2 quarters · filed 2015-02-24 | $1.10B derived: sum of 3 quarters · filed 2015-02-24 | $1.46B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-30 | $404.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $753.24M derived: sum of 2 quarters · filed 2015-02-24 | $1.12B derived: sum of 3 quarters · filed 2015-02-24 | $1.47B 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $349.07M 10-Q · filed 2013-11-05 | $713.31M derived: sum of 2 quarters · filed 2013-11-05 | $1.07B 10-Q · filed 2013-11-05 | $1.46B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-07-01 | $364.24M 10-Q · filed 2013-08-06 | $721.44M 10-Q · filed 2013-08-06 | $1.11B derived: sum of 3 quarters · filed 2014-02-25 | $1.41B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-04-01 | $357.19M 10-Q · filed 2013-05-06 | $742.37M derived: sum of 2 quarters · filed 2014-02-25 | $1.04B derived: sum of 3 quarters · filed 2014-02-25 | $1.37B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-01-01 | $385.18M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $686.97M derived: sum of 2 quarters · filed 2014-02-25 | $1.01B derived: sum of 3 quarters · filed 2014-02-25 | $1.32B 10-K · filed 2014-02-25 | ||||
| 2011-10-02 | $301.79M 10-Q · filed 2012-11-06 | $628.21M derived: sum of 2 quarters · filed 2012-11-06 | $934.33M 10-Q · filed 2012-11-06 | |||||
| 2011-07-03 | $326.42M 10-Q · filed 2012-08-07 | $632.54M 10-Q · filed 2012-08-07 | ||||||
| 2011-04-03 | $306.13M 10-Q · filed 2012-05-08 | |||||||
| 2011-01-02 | $1.16B 10-K · filed 2013-02-26 | |||||||
| 2010-01-03 | $1.06B 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |